Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Autophagy chaperone targets aggregation-prone proteins

April 27, 2021

Soticlestat reduces frequency of seizures in pediatric patients with DS and LGS

April 27, 2021

A new knock-in mouse model related to spinocerebellar ataxia 14

April 27, 2021

Shanghai Newsky Biotechnology presents new PLA2G7 inhibitors

April 26, 2021

Phase II trial of selective oral DHODH modulator vidofludimus in RRMS

April 23, 2021

Phase III study finds Xywav improves excessive daytime sleepiness

April 23, 2021

CVL-231 safe in healthy volunteers; evaluation in schizophrenia patients ongoing

April 23, 2021

Treatment begins in clinical trial of GNT-0004 gene therapy for Duchenne muscular dystrophy

April 22, 2021

UCB-0599 shows safety in older individuals with PD with age-related comorbidities

April 22, 2021

AUT-00206 improves auditory information processing in patients with schizophrenia

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...